ReviewGalen medical journal2022

Drug Resistance and Cardiovascular Safety of Second-Generation Anti-Androgens in Patients with Advanced Prostate Cancer : Second-Generation Antiandrogen Use in Advanced Prostate Cancer.

Venus Shahabi Raberi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.